Exane Derivatives »

Bio-techne Corporation shares owned by Exane Derivatives

Quarter-by-quarter ownership of Bio-techne Corporation (TECH) shares owned by Exane Derivatives from 13F filings

Historical chart of Exane Derivatives investment in Bio-techne Corporation

Tip: Access up to 7 years of quarterly data

All positions including Bio-techne Corporation held by Exane Derivatives consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-techne Corporation by Exane Derivatives

Quarter filed Position value Share count Share price at filing
2022-06-30 $141k 407 346.57
2022-03-31 $176k 407 433.01

More positions owned by Exane Derivatives

Spdr Sp 500 Ser.1 Option Call Option (SPY)
Microsoft Stock (MSFT)
Merck Stock (MRK)
Cameco Stock (CCJ)
Alphabet Cl.a Stock (GOOGL)
Ishares Core U.s. Stock (AGG)
Ishares Msci Glob. Stock (PICK)
Ishares Msci China Stock (MCHI)
Coca-cola Stock (KO)
Ishares Msci Acwi Stock (ACWI)
Invesco Qqq Stock (QQQ)
Citigroup Stock (C)
Ibm Stock (IBM)
Nexgen Energy Stock (NXE)
Dow Stock (DOW)

View all positions for Exane Derivatives

Top funds holding Bio-techne Corporation

Vanguard Group
Bamco
Select Equity
Neuberger Berman Group
Df Dent & Co
Mairs and Power
T. Rowe Price Associates
Bank of New York Mellon
Mackenzie Financial
Marshall Wace
William Blair Investment Management
Wellington Management Company
Norges Bank Investment Management
Jackson Square Partners
Charles Schwab Investment Management

View all funds holding Bio-techne Corporation